Evidence map›Paper›PMID 29067230›Full record

ArticleJournal of clinical & translational endocrinology2016

Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes.

Henry Zelada, Andres M Carnero, César Miranda-Hurtado, Diana Condezo-Aliaga, Cesar Loza-Munarriz, Pedro Aro-Guardia, Helard Manrique

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical & translational endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Henry ZeladaInternal Medicine Program, Louis A. Weiss Memorial Hospital, 4646 N Marine Dr, Chicago, IL 60640, USA.
Andres M CarneroSchool of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
César Miranda-HurtadoSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Diana Condezo-AliagaSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Cesar Loza-MunarrizInternal Medicine Program, Louis A. Weiss Memorial Hospital, 4646 N Marine Dr, Chicago, IL 60640, USA.
Pedro Aro-GuardiaSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Helard ManriqueDiabetes, Obesity and Nutrition Research Center, Lima, Peru.
Universidad Peruana Cayetano Heredia · PEWeiss Memorial Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo characterize and compare the beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes (T2D) and their non-diabetic, overweight and lean peers.

methodsCross-sectional study of 54 adolescents aged 10-19 years, distributed in three sex- and age-matched groups (n = 18): (i) adolescents with T2D; (ii) overweight adolescents without T2D; and (iii) lean adolescents without T2D, at the Diabetes, Obesity and Nutrition Research Center in Lima, Peru. Fasting glucose, insulin, C-peptide, and glycated hemoglobin were measured for all participants. In addition, a two-hour oral glucose tolerance test (OGTT, 1.75 mg of glucose/kg body weight) was performed, during which glucose and C-peptide were quantified. The homeostasis model assessment of insulin resistance (HOMA-IR) and beta-cell function (HOMA-B) were derived for all participants, and beta-cell function was further examined by the area under the curve (AUC) of C-peptide.

resultsThe median HOMA-IR score was higher in adolescents with T2D compared to lean adolescents (6.1 vs. 2.1; p = 0.002), but was not different from that of overweight adolescents (6.1 vs. 4.0; p = 0.322). The median HOMA-B was higher in overweight adolescents than in lean adolescents (256.9 vs. 134.2; p = 0.015), and adolescents with T2D (256.9 vs. 119.8; p = 0.011). The mean AUC of glucose in adolescents with T2D was 1.8-fold higher than that of overweight adolescents, and 1.9-fold higher than that of lean adolescents (p < 0.001). Although the median AUC of C-peptide in adolescents with T2D was lower than that of overweight and lean adolescents, this difference was not statistically significant (230.7 vs. 336.6 vs. 267.3 nmol/l120 min, respectively; p = 0.215).

conclusionAmong Peruvian adolescents with T2D, insulin resistance is the most prominent characteristic, rather than beta-cell dysfunction.

Indexed as

AdolescentInsulin resistanceObesityPancreatic beta cellsPeruType 2 diabetes

Identifiers

PMID29067230
PMCPMC5644437
OpenAlexW2397569122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.